Inhaled therapy for stable chronic obstructive pulmonary disease

被引：6

作者：

Antoniu, Sabina A. ^{[1
]}

Mihaescu, Traian ^{[1
]}

Donner, Claudio F. ^{[1
]}

机构：

[1] Clin Pulm Dis, Iasi 700115, Romania

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 06期

关键词：

bronchodilators; COPD; corticosteroids; inhaled therapy;

D O I：

10.1517/14656566.8.6.777

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Bronchodilators (anticholinergic drugs and beta 2-agonist drugs) represent the mainstay of chronic obstructive pulmonary disease treatment and can be combined with inhaled corticosteroids for greater efficacy. This review examines the role of short- and long-acting cholinergic drugs, together with that of short- and long-acting beta 2-agonist drugs. A brief analysis of the long-term use of corticosteroids in chronic obstructive pulmonary disease is made, with a review of the safety and possible side effects. Combination therapy is more frequently used due to its practicality and capacity to enhance compliance. The main studies on treatment combinations are also analyzed in this paper.

引用

页码：777 / 785

页数：9

共 60 条

[1]

Altose MD, 2000, NEW ENGL J MED, V343, P1902

[2]

[Anonymous], P AM THORAC SOC

[3]

APPLETON S, 2002, COCHRANE DB SYST REV, V3

[4]

Auerbach D, 1997, CHEST, V112, P1514